skip to content

Investor contacts

Roche investor relations group headquarters

F. Hoffmann-La Roche Ltd.
Investor Relations
CH-4070 Basel
Switzerland
View on Google Maps

For all general enquiries please call the Roche switchboard on
+41 61 688 1111

For IR requests use
+41 61 688 8880

+41 61 691 0014

Email IR Team

Our investor relations team

Bruno Eschli

Head of Investor Relations

Sabine Borngräber

IR Officer

Birgit Masjost

IR Officer

Beatrice Hau

Coordination

Melanie Wolf

Coordination

Eva Losert

Coordination

Roche investor relations group North America

Roche Holdings, Inc.
Genentech, Inc.
Investor Relations North America
1 DNA Way
South San Francisco, CA 94080
USA
View on Google Maps

For all general enquiries please call the Genentech switchboard on

+1 650 225 1000

For IR requests use

+1 650 225 5566

+1 650 225 8326

Email IR Team

Your contact person

Loren Kalm

Investor Relations Officer

Adverse event reporting

Please note that the provided investor contacts on this site are not to be used to report adverse events or to ask any questions regarding medical products.

Reporting side-effects related to our products should be sent to your Roche local safety contact. For country-specific contact details  Please visit this site.

Patients are being asked to primarily contact their personal physician